Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2025 Filed Jun 27, 2025 20:30 UTC |
Thompson Peter A.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001415889-25-018387 · form4-06272025_040612.xml · derivative · entry 1 Thompson Peter A. · CIK 0001357522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-06-24 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors. F2 · ownership.direct: Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 20:30 UTC |
SAUNDERS BRENT LDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001415889-25-018384 · form4-06272025_040607.xml · derivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-06-24 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 20:30 UTC |
Shawver LauraDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001415889-25-018382 · form4-06272025_040603.xml · derivative · entry 1 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-06-24 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors. Read SEC document |
| June 25, 2025 Filed Jun 27, 2025 20:30 UTC |
SCHNEIDER PHILLIP MDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $17.26 | $0.00 |
DisclosureSEC source: 0001415889-25-018383 · form4-06272025_040605.xml · derivative · entry 1 SCHNEIDER PHILLIP M · CIK 0001230051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-06-24 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 22:38 UTC |
Karas EricChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-25-017901 · form4-06202025_100641.xml · derivative · entry 3 Karas Eric · CIK 0001951287 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 559,588 Underlying: Common Stock · 15,000 shares Expires 2032-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 22:38 UTC |
Karas EricChief Commercial Officer
|
SaleCommon Stock | 15,000 | $16.00 | $240,000.00 |
DisclosureSEC source: 0001415889-25-017901 · form4-06202025_100641.xml · nonDerivative · entry 2 Karas Eric · CIK 0001951287 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,696 F1 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 22:38 UTC |
Karas EricChief Commercial Officer
|
Exercise / conversionCommon Stock | 15,000 | $1.50 | $22,500.00 |
DisclosureSEC source: 0001415889-25-017901 · form4-06202025_100641.xml · nonDerivative · entry 1 Karas Eric · CIK 0001951287 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
Fitzpatrick Alexander AChief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $5.58 | $0.00 |
DisclosureSEC source: 0001415889-25-014186 · form4-05222025_050505.xml · derivative · entry 3 Fitzpatrick Alexander A · CIK 0001398595 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2034-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vested on January 1, 2025, and the remaining shares will vest monthly thereafter over three years. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
Fitzpatrick Alexander AChief Legal Officer
|
SaleCommon Stock | 102,969 | $14.10 | $1,451,512.81 |
DisclosureSEC source: 0001415889-25-014186 · form4-05222025_050505.xml · nonDerivative · entry 2 Fitzpatrick Alexander A · CIK 0001398595 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,613 F2 · price: The weighted average sale price for the transaction reported was $14.0966 and the range of prices were between $14.02 and $14.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
Fitzpatrick Alexander AChief Legal Officer
|
Exercise / conversionCommon Stock | 100,000 | $5.58 | $558,000.00 |
DisclosureSEC source: 0001415889-25-014186 · form4-05222025_050505.xml · nonDerivative · entry 1 Fitzpatrick Alexander A · CIK 0001398595 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,355 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2024. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
SAUNDERS BRENT LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001415889-25-014185 · form4-05222025_050503.xml · derivative · entry 3 SAUNDERS BRENT L · CIK 0001268854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470,950 Underlying: Common Stock · 120,000 shares Expires 2031-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
SAUNDERS BRENT LDirector
|
SaleCommon Stock | 120,000 | $14.25 | $1,710,024.00 |
DisclosureSEC source: 0001415889-25-014185 · form4-05222025_050503.xml · nonDerivative · entry 2 SAUNDERS BRENT L · CIK 0001268854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The weighted average sale price for the transaction reported was $14.2502 and the range of prices were between $14.25 and $14.26. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
SAUNDERS BRENT LDirector
|
Exercise / conversionCommon Stock | 120,000 | $1.01 | $121,200.00 |
DisclosureSEC source: 0001415889-25-014185 · form4-05222025_050503.xml · nonDerivative · entry 1 SAUNDERS BRENT L · CIK 0001268854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
Scott Kathleen D.Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-25-014184 · form4-05222025_050501.xml · derivative · entry 4 Scott Kathleen D. · CIK 0001794284 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 752,330 Underlying: Common Stock · 50,000 shares Expires 2032-02-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
Scott Kathleen D.Chief Financial Officer
|
SaleCommon Stock | 50,000 | $14.10 | $705,165.00 |
DisclosureSEC source: 0001415889-25-014184 · form4-05222025_050501.xml · nonDerivative · entry 2 Scott Kathleen D. · CIK 0001794284 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,424 F2 · price: The weighted average sale price for the transaction reported was $14.1033 and the range of prices were between $14.10 and $14.115. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 20, 2025 Filed May 22, 2025 21:00 UTC |
Scott Kathleen D.Chief Financial Officer
|
Exercise / conversionCommon Stock | 50,000 | $1.50 | $75,000.00 |
DisclosureSEC source: 0001415889-25-014184 · form4-05222025_050501.xml · nonDerivative · entry 1 Scott Kathleen D. · CIK 0001794284 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,475 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2024. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:45 UTC |
Shawver LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,493 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-25-010395 · form4-04082025_040401.xml · derivative · entry 5 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,062 Underlying: Common Stock · 27,493 shares Expires 2032-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:45 UTC |
Shawver LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,509 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-25-010395 · form4-04082025_040401.xml · derivative · entry 4 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,555 Underlying: Common Stock · 22,509 shares Expires 2032-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:45 UTC |
Shawver LauraDirector
|
SaleCommon Stock | 50,002 | $12.30 | $615,074.60 |
DisclosureSEC source: 0001415889-25-010395 · form4-04082025_040401.xml · nonDerivative · entry 3 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,346 F1 · kind: The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The weighted average sale price for the transaction reported was $12.301 and the range of prices were between $12.0063 and $12.64. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:45 UTC |
Shawver LauraDirector
|
Exercise / conversionCommon Stock | 27,493 | $4.85 | $133,341.05 |
DisclosureSEC source: 0001415889-25-010395 · form4-04082025_040401.xml · nonDerivative · entry 2 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 20:45 UTC |
Shawver LauraDirector
|
Exercise / conversionCommon Stock | 22,509 | $4.85 | $109,168.65 |
DisclosureSEC source: 0001415889-25-010395 · form4-04082025_040401.xml · nonDerivative · entry 1 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 22:30 UTC |
Karas EricChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001415889-25-008796 · form4-03212025_060301.xml · derivative · entry 3 Karas Eric · CIK 0001951287 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 574,588 Underlying: Common Stock · 10,000 shares Expires 2032-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 22:30 UTC |
Karas EricChief Commercial Officer
|
SaleCommon Stock | 10,000 | $14.00 | $140,000.00 |
DisclosureSEC source: 0001415889-25-008796 · form4-03212025_060301.xml · nonDerivative · entry 2 Karas Eric · CIK 0001951287 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,696 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 22:30 UTC |
Karas EricChief Commercial Officer
|
Exercise / conversionCommon Stock | 10,000 | $1.50 | $15,000.00 |
DisclosureSEC source: 0001415889-25-008796 · form4-03212025_060301.xml · nonDerivative · entry 1 Karas Eric · CIK 0001951287 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,003 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2024. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:12 UTC |
Shawver LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 49,600 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-25-007438 · form4-03072025_100311.xml · derivative · entry 6 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,064 Underlying: Common Stock · 49,600 shares Expires 2032-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:12 UTC |
Shawver LauraDirector
|
SaleCommon Stock | 49,600 | $11.21 | $556,045.76 |
DisclosureSEC source: 0001415889-25-007438 · form4-03072025_100311.xml · nonDerivative · entry 4 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,346 F1 · kind: The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The weighted average sale price for the transaction reported was $11.2106 and the range of prices were between $11.00 and $11.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:12 UTC |
Shawver LauraDirector
|
Exercise / conversionCommon Stock | 49,600 | $4.85 | $240,560.00 |
DisclosureSEC source: 0001415889-25-007438 · form4-03072025_100311.xml · nonDerivative · entry 3 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 259,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:12 UTC |
Shawver LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 400 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-25-007438 · form4-03072025_100311.xml · derivative · entry 5 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,664 Underlying: Common Stock · 400 shares Expires 2032-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:12 UTC |
Shawver LauraDirector
|
SaleCommon Stock | 400 | $11.00 | $4,400.00 |
DisclosureSEC source: 0001415889-25-007438 · form4-03072025_100311.xml · nonDerivative · entry 2 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,346 F1 · kind: The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 22:12 UTC |
Shawver LauraDirector
|
Exercise / conversionCommon Stock | 400 | $4.85 | $1,940.00 |
DisclosureSEC source: 0001415889-25-007438 · form4-03072025_100311.xml · nonDerivative · entry 1 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:35 UTC |
Shawver LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,936 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001415889-25-002955 · form4-02042025_040201.xml · derivative · entry 5 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,064 Underlying: Common Stock · 40,936 shares Expires 2032-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:35 UTC |
Shawver LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,064 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001415889-25-002955 · form4-02042025_040201.xml · derivative · entry 4 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,064 shares Expires 2032-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:35 UTC |
Shawver LauraDirector
|
SaleCommon Stock | 50,000 | $12.31 | $615,565.00 |
DisclosureSEC source: 0001415889-25-002955 · form4-02042025_040201.xml · nonDerivative · entry 3 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,346 F1 · kind: The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The weighted average sale price for the transaction reported was $12.3113 and the range of prices were between $11.9732 and $12.76. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:35 UTC |
Shawver LauraDirector
|
Exercise / conversionCommon Stock | 40,936 | $4.85 | $198,539.60 |
DisclosureSEC source: 0001415889-25-002955 · form4-02042025_040201.xml · nonDerivative · entry 2 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:35 UTC |
Shawver LauraDirector
|
Exercise / conversionCommon Stock | 9,064 | $3.15 | $28,551.60 |
DisclosureSEC source: 0001415889-25-002955 · form4-02042025_040201.xml · nonDerivative · entry 1 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 23:24 UTC |
Shawver LauraDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001415889-25-001053 · form4-01072025_110124.xml · derivative · entry 3 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,064 Underlying: Common Stock · 50,000 shares Expires 2032-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 23:24 UTC |
Shawver LauraDirector
|
SaleCommon Stock | 50,000 | $11.10 | $555,065.00 |
DisclosureSEC source: 0001415889-25-001053 · form4-01072025_110124.xml · nonDerivative · entry 2 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,346 F1 · kind: The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The weighted average sale price for the transaction reported was $11.1013 and the range of prices were between $11.00 and $11.43. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 23:24 UTC |
Shawver LauraDirector
|
Exercise / conversionCommon Stock | 50,000 | $3.15 | $157,500.00 |
DisclosureSEC source: 0001415889-25-001053 · form4-01072025_110124.xml · nonDerivative · entry 1 Shawver Laura · CIK 0001551891 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Fitzpatrick Alexander AChief Legal Officer
|
GrantStock option (right to buy) · Derivative | 152,300 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000463 · form4-01032025_040130.xml · derivative · entry 1 Fitzpatrick Alexander A · CIK 0001398595 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,300 Underlying: Common Stock · 152,300 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Dorsey BrianChief Operating Officer
|
GrantStock option (right to buy) · Derivative | 261,900 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000462 · form4-01032025_040128.xml · derivative · entry 1 Dorsey Brian · CIK 0001380762 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,900 Underlying: Common Stock · 261,900 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
|
GrantStock Option (right to buy) · Derivative | 767,600 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000466 · form4-01032025_040134.xml · derivative · entry 2 Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 767,600 Underlying: Common Stock · 767,600 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
|
GrantStock option (right to buy) · Derivative | 261,900 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000466 · form4-01032025_040134.xml · derivative · entry 1 Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,900 Underlying: Common Stock · 261,900 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 261,900 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000464 · form4-01032025_040132.xml · derivative · entry 2 Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 261,900 Underlying: Common Stock · 261,900 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
|
GrantStock option (right to buy) · Derivative | 767,600 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000464 · form4-01032025_040132.xml · derivative · entry 1 Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 767,600 Underlying: Common Stock · 767,600 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Chakma JustinChief Business Officer
|
GrantStock option (right to buy) · Derivative | 274,100 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000461 · form4-01032025_040126.xml · derivative · entry 1 Chakma Justin · CIK 0001951238 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,100 Underlying: Common Stock · 274,100 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Scott Kathleen D.Chief Financial Officer
|
GrantStock option (right to buy) · Derivative | 176,700 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000460 · form4-01032025_040124.xml · derivative · entry 1 Scott Kathleen D. · CIK 0001794284 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,700 Underlying: Common Stock · 176,700 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:30 UTC |
Karas EricChief Commercial Officer
|
GrantStock option (right to buy) · Derivative | 152,300 | $0.00 Strike: $10.71 | $0.00 |
DisclosureSEC source: 0001415889-25-000459 · form4-01032025_040122.xml · derivative · entry 1 Karas Eric · CIK 0001951287 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,300 Underlying: Common Stock · 152,300 shares Expires 2035-01-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025. Read SEC document |
| December 17, 2024 Filed Dec 19, 2024 21:20 UTC |
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
|
SaleCommon Stock | 50,000 | $11.67 | $583,525.00 |
DisclosureSEC source: 0001415889-24-029852 · form4-12192024_041203.xml · nonDerivative · entry 3 Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 Disclosed balance after: 1,098,499 F1 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023. F4 · price: The weighted average sale price for the transaction reported was $11.6705, and the range of prices were between $11.56 and $11.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F5 · ownership.nature: The shares are held in trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of the trust. Read SEC document |
| December 17, 2024 Filed Dec 19, 2024 21:20 UTC |
Tanimoto SarinaCHIEF MEDICAL OFFICER · 10% owner
|
SaleCommon Stock | 50,000 | $11.67 | $583,575.00 |
DisclosureSEC source: 0001415889-24-029852 · form4-12192024_041203.xml · nonDerivative · entry 2 Tanimoto Sarina · CIK 0001951291 · CHIEF MEDICAL OFFICER · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020 Disclosed balance after: 1,297,447 F1 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023. F2 · price: The weighted average sale price for the transaction reported was $11.6715 and the range of prices were between $11.56 and $11.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F3 · ownership.nature: The Reporting Person is trustee of the trust. Read SEC document |
| December 17, 2024 Filed Dec 19, 2024 21:20 UTC |
Lowenthal Richard EDirector · PRESIDENT AND CEO · 10% owner
|
SaleCommon Stock | 50,000 | $11.67 | $583,525.00 |
DisclosureSEC source: 0001415889-24-029851 · form4-12192024_041201.xml · nonDerivative · entry 3 Lowenthal Richard E · CIK 0001378550 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 Disclosed balance after: 1,098,499 F1 · shares: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023. F4 · price: The weighted average sale price for the transaction reported was $11.6705, and the range of prices were between $11.56 and $11.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F5 · ownership.nature: The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.